FDA — authorised 23 May 1996
- Application: BLA020162
- Marketing authorisation holder: FERRING
- Local brand name: ACTHREL
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA authorised Acthrel on 23 May 1996
Yes. FDA authorised it on 23 May 1996.
FERRING holds the US marketing authorisation.